Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	168.96B +19.3%
Revenue (ttm)	134.98B -2.8%
Net Income	15.75B +2.2%
EPS	1,776.91 +2.5%
Shares Out	8.80M
PE Ratio	10.81
Forward PE	n/a
Dividend	1,500.00 (7.81%)
Ex-Dividend Date	Mar 21, 2025

Volume	100
Average Volume	1,566
Open	18,100
Previous Close	19,000
Day's Range	18,100 - 18,100
52-Week Range	16,200 - 23,100
Beta	0.12
RSI	51.78
Earnings Date	Jan 23, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. Phon...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 15.55 billion, a decrease of -14.28%.